Cis‐diamminedichloroplatinum has been proven to be an effective neoplastic agent. Nephrotoxicity and ototoxicity are two prominent side effects of this drug. Investigation of ototoxicity has been limited to auditory function. This report details the first known case of vestibular toxicity following platinum therapy. In addition, a prospective vestibular testing program is reported. Cancer 47:857–8589, 1981.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Mar 1 1981|
ASJC Scopus subject areas
- Cancer Research